EFEMP2
Basic information
Region (hg38): 11:65866441-65873592
Links
Phenotypes
GenCC
Source:
- cutis laxa, autosomal recessive, type 1B (Definitive), mode of inheritance: AR
- cutis laxa, autosomal recessive, type 1B (Strong), mode of inheritance: AR
- cutis laxa, autosomal recessive, type 1B (Strong), mode of inheritance: AR
- cutis laxa, autosomal recessive, type 1B (Strong), mode of inheritance: AR
- autosomal recessive cutis laxa type 1 (Supportive), mode of inheritance: AR
- lethal arteriopathy syndrome due to fibulin-4 deficiency (Supportive), mode of inheritance: AR
- familial thoracic aortic aneurysm and aortic dissection (Moderate), mode of inheritance: AR
- cutis laxa, autosomal recessive, type 1B (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cutis laxa, autosomal recessive type IB | AR | Cardiovascular | Manifestations can include cardiovascular anomalies, including aortic dilatation and aortic aneurysms, and surveillance may allow early detection and management (eg, with beta-blockers and angiotensin-receptor inhibitors), which can decrease morbidity and mortality; Cigarette smoking should be avoided due to risk of exacerbation of pulmonary manifestations (including emphysema) | Cardiovascular; Dermatologic; Musculoskeletal; Pulmonary | 16685658; 17937443; 19664000; 20389311; 21563328; 22440127; 23212998 |
ClinVar
This is a list of variants' phenotypes submitted to
- Cutis laxa, autosomal recessive, type 1B (10 variants)
- Cardiovascular phenotype (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EFEMP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 126 | 132 | ||||
missense | 186 | 199 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
splice region | 1 | 7 | 13 | 21 | ||
non coding | 12 | 54 | 14 | 80 | ||
Total | 10 | 14 | 212 | 183 | 16 |
Highest pathogenic variant AF is 0.00000657
Variants in EFEMP2
This is a list of pathogenic ClinVar variants found in the EFEMP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-65866515-G-C | Cutis laxa, autosomal recessive, type 1B | Benign (Jan 12, 2018) | ||
11-65866613-G-A | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Jan 13, 2018) | ||
11-65866636-G-A | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Jan 13, 2018) | ||
11-65866671-T-G | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Jan 12, 2018) | ||
11-65866736-T-C | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Jan 13, 2018) | ||
11-65866744-C-T | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Jan 12, 2018) | ||
11-65866752-G-GC | Cutis laxa, recessive | Uncertain significance (Jun 14, 2016) | ||
11-65866803-C-T | Cutis laxa, autosomal recessive, type 1B | Conflicting classifications of pathogenicity (Jul 17, 2018) | ||
11-65866898-G-A | Likely benign (Feb 01, 2018) | |||
11-65866915-T-C | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Jan 13, 2018) | ||
11-65866925-G-T | Cardiovascular phenotype • Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Mar 13, 2022) | ||
11-65866927-G-A | Cardiovascular phenotype | Likely benign (Jan 18, 2020) | ||
11-65866939-A-C | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Mar 30, 2021) | ||
11-65866944-C-T | Cutis laxa, autosomal recessive, type 1B • Cardiovascular phenotype | Uncertain significance (Dec 11, 2023) | ||
11-65866945-G-A | Cutis laxa, autosomal recessive, type 1B | Likely benign (Oct 15, 2023) | ||
11-65866945-G-C | Cutis laxa, autosomal recessive, type 1B | Likely benign (Feb 19, 2021) | ||
11-65866948-G-A | Cutis laxa, autosomal recessive, type 1B | Likely benign (Jul 20, 2022) | ||
11-65866959-C-T | Cardiovascular phenotype | Uncertain significance (Apr 27, 2024) | ||
11-65866960-AGAGCTGGCCCG-A | Uncertain significance (Sep 19, 2017) | |||
11-65866961-G-T | Cardiovascular phenotype | Uncertain significance (Apr 28, 2023) | ||
11-65866967-G-A | Cutis laxa, autosomal recessive, type 1B | Uncertain significance (Apr 25, 2018) | ||
11-65866970-C-T | Cardiovascular phenotype | Uncertain significance (Apr 11, 2022) | ||
11-65866971-G-A | Cutis laxa, autosomal recessive, type 1B • Cardiovascular phenotype | Uncertain significance (Sep 01, 2021) | ||
11-65866993-G-T | Cardiovascular phenotype | Likely benign (Jun 21, 2024) | ||
11-65866999-C-G | Cardiovascular phenotype | Uncertain significance (Mar 05, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EFEMP2 | protein_coding | protein_coding | ENST00000307998 | 10 | 7152 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00819 | 0.991 | 125727 | 0 | 19 | 125746 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.976 | 236 | 282 | 0.836 | 0.0000203 | 2896 |
Missense in Polyphen | 73 | 105.53 | 0.69172 | 1105 | ||
Synonymous | -1.70 | 142 | 118 | 1.20 | 0.00000913 | 856 |
Loss of Function | 3.03 | 8 | 24.0 | 0.333 | 0.00000113 | 268 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000304 | 0.000304 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Disease
- DISEASE: Cutis laxa, autosomal recessive, 1B (ARCL1B) [MIM:614437]: A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. The clinical spectrum of autosomal recessive cutis laxa is highly heterogeneous with respect to organ involvement and severity. ARCL1B features include emphysema, lethal pulmonary artery occlusion, aortic aneurysm, cardiopulmonary insufficiency, birth fractures, arachnodactyly, and fragility of blood vessels. {ECO:0000269|PubMed:16685658, ECO:0000269|PubMed:17937443, ECO:0000269|PubMed:19664000}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Extracellular matrix organization;Molecules associated with elastic fibres;Elastic fibre formation
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.125
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.06
Haploinsufficiency Scores
- pHI
- 0.173
- hipred
- Y
- hipred_score
- 0.589
- ghis
- 0.616
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.452
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Efemp2
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; skeleton phenotype; vision/eye phenotype; limbs/digits/tail phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- elastic fiber assembly
- Cellular component
- extracellular region;basement membrane;collagen-containing extracellular matrix;extracellular exosome;extracellular vesicle
- Molecular function
- extracellular matrix structural constituent;calcium ion binding;protein binding